NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

XSurgical Welcomes U.S. Department of Defense’s Dr. Darrin Frye as Speaker

Dr. Darrin Frye

XSurgical, a firm developing and bringing to market a remotely controlled surgical robot, welcomed U.S. Department of Defense’s Dr. Darrin Frye as a speaker on the needs of today’s military health care providers when protecting and treating warfighters on the challenging battlefields.

Frye’s current mission is to provide oversight support and assistance in the visioning and support of the research and development of Defense Health capabilities that will enable military health care providers to protect and treat warfighters so they may continue to dominate on the battlefields of tomorrow. Frye explained that the changes in today’s battlefields and air space have made it challenging to evacuate patients to a different location for treatment making surgical robotics technology especially promising to expeditionary medical, and theater hospital experts.

Having served in the Army Reserves as a Preventive Medicine Officer for 13 years, Frye now operates in the JPC-1 office within the United States Army Medical Research and Material Command (USAMRMC), supporting the J-9 (Research and Development Directorate), Defense Health Agency. He provides oversight support and assistance in the visioning, and supports research to close Defense Health capability gaps that will enable military health care providers to protect and treat warfighters so they may continue to dominate on the battlefields of tomorrow.

His prior assignments include the 807th Medical Command, supporting Operation Enduring Freedom 2001-2007 where he served as a subject matter expert on Disease Non-Battle Injury (DNBI). In 2003, he was mobilized by Task Force Ironhorse with the 4th Infantry Division, providing medical mission support.

XSurgical is working to develop and bring to market a remotely controlled surgical robot, which can be deployed in situations of disaster recovery, battlefield and travels into space. The surgical robot will be able to perform surgery, guided by surgeons from remote locations. The concept has received interest from key people at the Department of Defense. XSurgical is also working to develop the artificial intelligence to make subsequent robots fully autonomous.

“We thank Dr. Frye for his service and his expertise in the challenges of providing essential medical treatment in challenging environments,” said XSurgical CEO and Founder Gianluca De Novi. “Dr. Frye brings important firsthand experience on the battlefield and is passionate in his mission to provide the very best treatment for our service men and women.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X